During the past decade, Atlantic Urological Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Atlantic Urological Associates" are "Prostatic Neoplasms" (2 trials) and "Advanced Prostate Cancer" (1 trials). Many other conditions were trialed in "Atlantic Urological Associates" in a lesser frequency.

Most popular intervention types in "Atlantic Urological Associates" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Leuprolide acetate" (1 trials) and "sipuleucel-T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlantic Urological Associates" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Atlantic Urological Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Atlantic Urological Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atlantic Urological Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".